Crinetics Pharmaceuticals to Release Critical Phase 2 Data and Commercial Strategy Update

San Diego, Sunday, 4 January 2026.
Crinetics is set to reveal pivotal Phase 2 data for its congenital adrenal hyperplasia therapy and update on PALSONIFY’s commercial progress during a conference call this Monday.